Literature DB >> 15531279

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.

T R Pedersen, J Kjekshus, K Berg, T Haghfelt, O Faergeman, G Faergeman, K Pyörälä, T Miettinen, L Wilhelmsen, A G Olsson, H Wedel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15531279     DOI： 10.1016/j.atherosclerosissup.2004.08.027

Source DB:  PubMed          Journal:  Atheroscler Suppl        ISSN： 1567-5688            Impact factor:   3.235


× No keyword cloud information.
  67 in total

1.  Twenty questions on atherosclerosis.

Authors:  W C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-04

Review 2.  Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials.

Authors:  Yangchun Liu; Qiang Su; Lang Li
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

3.  Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk.

Authors:  Dominic Mitchell; Jason R Guertin; Jacques LeLorier
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

4.  A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention.

Authors:  Dominic Mitchell; Jason R Guertin; Anick Dubois; Marie-Pierre Dubé; Jean-Claude Tardif; Ange Christelle Iliza; Fiorella Fanton-Aita; Alexis Matteau; Jacques LeLorier
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

5.  Statins and total (not LDL) cholesterol concentration and outcome of myocardial infarction: results from a meta-analysis and an observational study.

Authors:  Xia Sheng; Li Wei; Michael J Murphy; Thomas M MacDonald
Journal:  Eur J Clin Pharmacol       Date:  2009-11       Impact factor: 2.953

Review 6.  Genomic view of factors leading to plaque instability.

Authors:  Sonny Dandona; Robert Roberts
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

Review 7.  Dyslipidemia in patients with chronic and end-stage kidney disease.

Authors:  Jad Omran; Ashraf Al-Dadah; Kevin C Dellsperger
Journal:  Cardiorenal Med       Date:  2013-07-13       Impact factor: 2.041

Review 8.  Progress and perspectives in plant sterol and plant stanol research.

Authors:  Peter J H Jones; Maryam Shamloo; Dylan S MacKay; Todd C Rideout; Semone B Myrie; Jogchum Plat; Jean-Baptiste Roullet; David J Baer; Kara L Calkins; Harry R Davis; P Barton Duell; Henry Ginsberg; Helena Gylling; David Jenkins; Dieter Lütjohann; Mohammad Moghadasian; Robert A Moreau; David Mymin; Richard E Ostlund; Rouyanne T Ras; Javier Ochoa Reparaz; Elke A Trautwein; Stephen Turley; Tim Vanmierlo; Oliver Weingärtner
Journal:  Nutr Rev       Date:  2018-10-01       Impact factor: 7.110

Review 9.  Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

Authors:  Marco Tuccori; Sabrina Montagnani; Stefania Mantarro; Alice Capogrosso-Sansone; Elisa Ruggiero; Alessandra Saporiti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

Review 10.  The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations.

Authors:  Allyson M Schweitzer; Molly A Gingrich; Thomas J Hawke; Irena A Rebalka
Journal:  Eur J Appl Physiol       Date:  2020-04-04       Impact factor: 3.078
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.